1. Platinum distribution inintraperitoneal tumors afterintraperitoneal cisplatin treatment

   • Gerrit Los
   • Peter H. A. Mutsaers
   • J. Gordon McVie

   Original Articles Pages: 389 - 394

2. A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP

   • Brenda J. Foster
   • Bonnie J. Harding
   • Brian Leyland-Jones

   Original Articles Pages: 395 - 404

3. Modification of methyliminodiacetato-trans-R, R-1,2-diamminocyclohexane platinum(II) pharmacology using a platinum-specific monoclonal antibody

   • Michael G. Rosenblum
   • James L. Murray
   • Abdul R. Khokhar

   Original Articles Pages: 405 - 410

4. Metallothionein-like proteins and cell resistance tocis-dichlorodiammineplatinum(II) in L1210 cells

   • Paul Farnworth
   • Brian Hillcoat
   • Ian Roos

   Original Articles Pages: 411 - 417

5. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology

   • Li-Ming Wang
   • J. Courtland White
   • Robert L. Capizzi

   Original Articles Pages: 418 - 424

6. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo

   • Steadman D. Harrison Jr.
   • Jacqueline Plowman
   • Daniel P. Griswold Jr.

   Original Articles Pages: 425 - 429

7. DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and-resistant human colon carcinoma cells

   • Laura Capolongo
   • Giorgio Belvedere
   • Maurizio D'Incalci

   Original Articles Pages: 430 - 434

8. Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer

   • Miguel H. Bronchud
   • Jennifer M. Margison
   • Peter M. Wilkinson

   Original Articles Pages: 435 - 439

9. Pharmacokinetics of reduced folates after short-term infusion of d, 1-folinic acid

   • Andreas Schalhorn
   • Michael Kühl
   • Volkmar Nüssler

   Original Articles Pages: 440 - 444

10. Pharmacokinetics of 4-demethoxydaunorubicin in cancer patients

    • Luisa Zanette
    • Massimo Zucchetti
    • Maurizio D'Incalci

    Original Articles Pages: 445 - 448

11. Ondansetron — a new safe and effective antiemetic in patients receiving high-dose melphalan

    • C. V. Viner
    • P. J. Selby
    • T. J. McElwain

    Original Articles Pages: 449 - 453

12. Extremely prolonged continuous intraperitoneal infusion of cytosine arabinoside

    • Saeeda Kirmani
    • Solomon Zimm
    • Stephen B. Howell

    Original Articles Pages: 454 - 458

13. Toxicity of intra-arterial doxorubicin in locally advanced breast cancer

    • Christopher J. Twelves
    • Murid A. Chaudary
    • Robert D. Rubens

    Short Communication Pages: 459 - 462

14. Phase II study of teniposide in advanced breast cancer

    • Janne Boas
    • Dorte Rasmussen
    • Per Dombernowsky

    Short Communication Pages: 463 - 464